Saudi Arabia: More than a million doses of Corona vaccine have been distributed


RIYADH – The Saudi Ministry of Health announced the distribution of more than one million doses of anti-corona virus vaccine through 405 vaccination sites inside the Kingdom, in the context of its keenness to achieve the largest expansion in the granting of the vaccine.

The Saudi Minister of Health, Dr. Tawfiq Al-Rabiah, revealed in an interview with Al-Arabiya that the ministry will provide vaccines against the emerging corona virus in community pharmacies free of charge inside the Kingdom.

Al-Rabiah said that the Ministry of Health has expanded, with distribution starting from vaccination centers, then hospitals and health centers, as well as private hospitals, and we are expanding into community pharmacies.

When asked about the free vaccination, Al-Rabiah said: “We will provide the vaccines in a nearby location for the recipient, and they are always free.”

The Food and Drug Administration in the Kingdom is currently evaluating a number of anti-Coronavirus vaccines, confirming readiness for the rapid expansion of the vaccination process in various regions of Saudi Arabia, which is proceeding at a high rate.

The Ministry of Health indicated that the vaccines currently approved in Saudi Arabia or those currently being evaluated are approved for use starting from the age of 16 or 18 years. She explained that their appointments are scheduled according to the “priority categories” approved in the “national strategy for immunization from the emerging corona virus.”

The Ministry of Health allowed the submission of dates for the “second dose” of the Corona vaccine for those wishing to have their doses rescheduled through the My Health app, and the directive was also directed to link the acceptance of participants in the Hajj season to receiving the vaccine against the Corona virus and the cause of “Covid-19 ″, and considering it the main condition for participation.

Saudi Arabia began the Corona vaccination campaign on December 17, 2020, after the Food and Drug Authority approved the registration of the “Pfizer-Biontech” vaccine, and priority was given to three categories: people over the age of 65, those suffering from chronic diseases, and those whose work nature requires Being on the front lines to confront the epidemic, as workers in the health sector.


Please enter your comment!
Please enter your name here